Drug ...market ... some pharmaceutical companies worry the lawsuit could put a damper on future drug development. Jeff Newman, partner at Boston law firm Prince, Lobel, Glovsky and Tye, takes a ...

...pharmaceutical ...drugs ...marketing,...drug development and regulatory submissions to be done on a more predictable timeline.” At Lilly, Ruberg adds, SAS enables operational efficiency, ...

...iss pharmaceutical giant Novartis is challenging the Indian government's refusal to allow it to patent the cancer drug Glivec. Novartis says it needs patents to protect drug development in the ...

38

...Drug ...drugs....markets. Health economics: treatment access and justice issues. Pharmacogenomics and gene prophecy. Ethical issues in pharmaceuticals. HIV and AIDS. Patrick Dixon, conference ...

123

...cant drug development setback is pushing shares of drug giant Eli Lilly to a ten-year low, and that is also sparking a relief rally in the stocks of two other drug makers, reports CNBC's Mike ...